Bcl-2抑制剂APG-2575-话题@MedSci - 梅斯（MedSci）

#Bcl-2抑制剂APG-2575#

4篇内容 | 978人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1773144, encodeId=c6cc1e73144e4, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制剂APG-2575#</a>, objectTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, objectType=article, longId=200404, objectId=d860200404a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d860200404a6, replyNumber=0, likeNumber=66, createdTime=2020-12-17, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d860200404a6, moduleTitle=FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d860200404a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773145, encodeId=80cc1e73145ea, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制剂APG-2575#</a>, objectTitle=美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）, objectType=article, longId=206517, objectId=375420651efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375420651efe, replyNumber=0, likeNumber=61, createdTime=2021-11-27, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375420651efe, moduleTitle=美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=375420651efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773143, encodeId=05bc1e7314325, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制剂APG-2575#</a>, objectTitle=亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症, objectType=article, longId=197635, objectId=8f5319e6350c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5319e6350c, replyNumber=0, likeNumber=73, createdTime=2021-01-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5319e6350c, moduleTitle=亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8f5319e6350c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773142, encodeId=46af1e7314200, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制剂APG-2575#</a>, objectTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, objectType=article, longId=191730, objectId=1f9c191e301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9c191e301a, replyNumber=0, likeNumber=77, createdTime=2020-08-20, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9c191e301a, moduleTitle=亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f9c191e301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Bcl-2抑制剂APG-2575

2020-05-29

minzju5065 (审核中...)

前往app查看评论内容

#Bcl-2抑制剂APG-2575#

FDA授予Bcl-2抑制剂APG-2575孤儿药资格，用于治疗慢性淋巴细胞性白血病

2020-12-17

minzju5065 (审核中...)

前往app查看评论内容

#Bcl-2抑制剂APG-2575#

美国FDA授予Bcl-2抑制剂APG-2575第五个孤儿药称号，用以治疗滤泡性淋巴瘤（FL）

2021-11-27

zhouqu_8 (审核中...)

前往app查看评论内容

#Bcl-2抑制剂APG-2575#

亚盛医药获得FDA授予第二个孤儿药称号：Bcl-2抑制剂APG-2575治疗华氏巨球蛋白血症

2021-01-12

minzju5065 (审核中...)

前往app查看评论内容

#Bcl-2抑制剂APG-2575#

亚盛药业的Bcl-2抑制剂APG-2575用于慢性淋巴细胞白血病或小淋巴细胞淋巴瘤的Ib/II期临床，获得NMPA的批准

2020-08-20

科室
- - 订阅+
  - 更多科室
工具
服务